Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system

Medicine & Life Sciences

1. Biomarkers 100%
2. Alzheimer Disease 83%
3. Amyloid 81%
4. National Institute on Aging (U.S.) 54%
5. Brain 33%
6. Cognitive Dysfunction 33%
7. Cerebrovascular Disorders 20%
8. Organized Financing 16%
9. Amyloidosis 15%
10. Elderly 14%
11. Dementia 12%
12. Amyloid angiopathy 11%
13. National Institute of Neurological Disorders and Stroke (U.S.) 10%
14. Wounds and Injuries 9%
15. Guidelines 9%
16. Demography 8%
17. Neurobehavioral Manifestations 8%
18. Disease Progression 5%
19. Population 5%